Holen Sie sich die Stockscreener-App
1.24
0.80%
-0.01
Handel nachbörslich:
1.23
-0.01
-0.81%
Schlusskurs vom Vortag:
$1.25
Offen:
$1.25
24-Stunden-Volumen:
6.46M
Relative Volume:
0.84
Marktkapitalisierung:
$791.14M
Einnahmen:
$29.48M
Nettoeinkommen (Verlust:
$-201.19M
KGV:
-3.875
EPS:
-0.32
Netto-Cashflow:
$-216.50M
1W Leistung:
+13.76%
1M Leistung:
-5.34%
6M Leistung:
-3.13%
1J Leistung:
-68.77%
1-Tages-Spanne:
$1.23
$1.28
1-Wochen-Bereich:
$1.04
$1.28
52-Wochen-Spanne:
$1.04
$4.205
Geron Corp Stock (GERN) Company Profile
Firmenname
Geron Corp
Sektor
Branche
Telefon
(650) 473-7700
Adresse
919 EAST HILLSDALE BOULEVARD, FOSTER CITY, CA
Vergleichen Sie GERN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GERN
Geron Corp
|
1.24 | 740.49M | 29.48M | -201.19M | -216.50M | -0.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
434.19 | 106.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
681.72 | 68.81B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.74 | 58.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
889.89 | 53.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
377.47 | 36.43B | 4.56B | -176.77M | 225.30M | -1.7177 |
Geron Corp Stock (GERN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-10 | Fortgesetzt | Goldman | Sell |
| 2025-05-08 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2025-02-27 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2025-02-26 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-11-05 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-09-09 | Eingeleitet | Leerink Partners | Outperform |
| 2024-04-30 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-04-29 | Eingeleitet | TD Cowen | Buy |
| 2024-03-15 | Bestätigt | Needham | Buy |
| 2023-09-12 | Hochstufung | Goldman | Neutral → Buy |
| 2023-03-28 | Eingeleitet | Goldman | Neutral |
| 2022-10-28 | Eingeleitet | Wedbush | Outperform |
| 2022-07-28 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-11-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-02-18 | Fortgesetzt | B. Riley Securities | Buy |
| 2020-08-03 | Eingeleitet | Stifel | Buy |
| 2019-11-19 | Fortgesetzt | B. Riley FBR | Buy |
| 2019-09-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-08-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-04-09 | Hochstufung | Needham | Hold → Buy |
| 2019-01-31 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2018-10-02 | Herabstufung | B. Riley FBR | Buy → Neutral |
| 2018-07-05 | Eingeleitet | B. Riley FBR, Inc. | Buy |
| 2016-09-13 | Bestätigt | FBR & Co. | Outperform |
| 2016-09-13 | Bestätigt | FBR Capital | Outperform |
| 2015-12-07 | Bestätigt | Piper Jaffray | Overweight |
| 2015-04-21 | Eingeleitet | Oppenheimer | Outperform |
| 2014-06-12 | Hochstufung | MLV & Co | Hold → Buy |
| 2014-03-12 | Herabstufung | MLV & Co | Buy → Hold |
| 2013-12-10 | Bestätigt | MLV & Co | Buy |
| 2013-12-10 | Hochstufung | Needham | Hold → Buy |
| 2013-11-08 | Bestätigt | MLV & Co | Buy |
| 2013-10-16 | Eingeleitet | MLV & Co | Buy |
| 2012-08-30 | Eingeleitet | Stifel Nicolaus | Buy |
| 2012-06-28 | Eingeleitet | Needham | Hold |
Alle ansehen
Geron Corp Aktie (GERN) Neueste Nachrichten
Published on: 2025-11-12 20:57:08 - newser.com
Published on: 2025-11-12 14:25:01 - newser.com
Can Geron Corporation (GON) stock resist broad market declinesJuly 2025 Final Week & Proven Capital Preservation Tips - newser.com
Why Geron Corporation (GON) stock stays on buy listsTrade Volume Report & Low Risk Growth Stock Ideas - newser.com
After a lackluster first drug launch, a new CEO is finding Geron’s commercial footing - Yahoo Finance
Is Geron Corporation stock a good choice for value investorsTrade Exit Report & Low Drawdown Momentum Trade Ideas - newser.com
Geron at Stifel 2025 Healthcare Conference: Strategic Adjustments for Rytelo - Investing.com
Geron Corp. Hits Day Low of $1.04 Amid Price Pressure - Markets Mojo
Can Geron Corporation (GON) stock attract analyst upgrades2025 Trading Volume Trends & Precise Trade Entry Recommendations - newser.com
Will Geron Corporation stock outperform growth indexesPrice Action & Stepwise Entry and Exit Trade Signals - newser.com
Why Geron Corporation stock remains on watchlistsTrade Risk Report & Free High Return Stock Watch Alerts - newser.com
Will Geron Corporation stock deliver strong dividend growthTrade Risk Summary & Daily Stock Trend Watchlist - newser.com
Why analysts maintain buy rating on Geron Corporation (GON) stockQuarterly Trade Review & AI Driven Stock Movement Reports - newser.com
Market reaction to Geron Corporation’s recent newsProfit Target & Community Consensus Trade Alerts - newser.com
Geron Corporation (NASDAQ:GERN) Q3 2025 Earnings Call Transcript - Insider Monkey
Geron: Q3 Earnings Snapshot - CT Insider
How Geron Corporation stock performs in stagflationEarnings Summary Report & Stepwise Trade Signal Implementation - newser.com
Will earnings trigger a reversal in Geron CorporationSwing Trade & Smart Investment Allocation Tips - newser.com
Aug Fed Impact: Can Geron Corporation stock deliver consistent earnings growthEarnings Trend Report & Reliable Breakout Stock Forecasts - Fundação Cultural do Pará
Can Geron Corporation stock sustain free cash flow growthEarnings Recap Report & Expert Approved Momentum Trade Ideas - newser.com
Geron Q3 2025 Earnings Call Transcript - MarketBeat
Geron Corp (GERN) Q3 2025 Earnings Call Highlights: Revenue Growth Amidst RYTELO Demand Challenges - Investing.com Canada
Geron Corporation (GERN) Q3 2025 Earnings Highlight RYTELO Devel - GuruFocus
Geron stock price target lowered to $2 by Leerink on Rytelo sales - Investing.com
Geron Corp reports results for the quarter ended September 30Earnings Summary - TradingView
GERN: Needham Maintains Buy Rating but Reduces Price Target | GE - GuruFocus
Published on: 2025-11-05 14:25:00 - Fundação Cultural do Pará
Geron Q3 2025 slides: RYTELO revenue misses targets despite pipeline progress - Investing.com
Geron Shrinks Quarterly Losses And Meets Revenue Goals - Finimize
Earnings call transcript: Geron Q3 2025 reveals revenue miss, stock dips By Investing.com - Investing.com South Africa
Earnings call transcript: Geron Q3 2025 reveals revenue miss, stock dips - Investing.com
Geron (GERN) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance
Geron Corporation (GERN) Adjusts 2025 Operating Expense Forecast - GuruFocus
Geron (GERN) Reports Q3 Revenue Below Expectations, Focuses on R - GuruFocus
Geron earnings matched, revenue fell short of estimates - Investing.com
Geron Corp Q3 2025 Earnings: EPS Meets Estimates at -$0.03, Reve - GuruFocus
[8-K] GERON CORP Reports Material Event | GERN SEC FilingForm 8-K - Stock Titan
Geron Corporation Reports Third Quarter 2025 Financial Results and Recent Business Highlights - Yahoo Finance
What Do Investors Think About Geron Corporation (GERN) Following Q2 Results? - MSN
Geron (NASDAQ: GERN) to join fireside chats at Stifel and Evercore on Nov 11 and Dec 2 - Stock Titan
Geron Corporation to Present at Upcoming Investor Conferences - Yahoo Finance
What consensus target says about Geron Corporation (GON) stock2025 Earnings Impact & Verified Swing Trading Watchlists - newser.com
Why Geron Corporation (GON) stock attracts HNW investors2025 Investor Takeaways & High Accuracy Swing Entry Alerts - newser.com
Geron (NASDAQ: GERN) announces 5 RYTELO studies at ASH, IMerge oral and MF biomarkers - Stock Titan
Geron Corporation Announces Five Presentations Selected for ASH 2025 Highlighting Clinical Activity of RYTELO® (imetelstat) in Myeloid Hematologic Malignancies - Yahoo Finance
Geron Corporation (GERN) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Geron Corporation (GERN) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Geron (NASDAQ:GERN) Earns "Sell (E+)" Rating from Weiss Ratings - MarketBeat
What analyst consensus says on Geron Corporation stockJuly 2025 Rallies & Comprehensive Market Scan Reports - newser.com
Finanzdaten der Geron Corp-Aktie (GERN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.62%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):